Pharmaceutical Giants Win 2008 China Charity Awards
This article was originally published in PharmAsia News
China's Ministry of Civil Affairs recently announced its 2008 China Charity Award, which recognizes the outstanding achievements of individuals, enterprises and charity programs in 2008. The award represents the most prestigious in the country honoring corporate social responsibility. In the foreign company segment, pharmaceutical and medical device manufacturers Sanofi-Aventis, AstraZeneca, Novartis, Hualan Biological Engineering, Dupromise Medicine, Siemens and Canon China are among the winners. Following the Sichuan earthquake in May this year, Sanofi and Novartis each donated RMB 15 million ($2 million) in cash and medicine, while AstraZeneca allocated some RMB 14.6 million worth of donations, medicine and materials to support post-disaster reconstruction (PharmAsia News, May 19, 2008). (Click here for more - Chinese Language)
You may also be interested in...
Donations have been pouring in for the Sichuan earthquake victims in China, with pharmaceutical MNCs doing their part. PharmAsia News provides a round up below of medical product company contributions as reported in the Chinese media
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.
Wholesalers are given three more years to set up electronic systems to verify saleable returns under another reprieve from the FDA. Yet the reprieve does not extend to manufacturers, who must respond within 24 hours to wholesalers’ requests to manually verify that a returned product is not suspect.